Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-10-14 05:26Summary of Key Points Core Viewpoint - The company has provided a joint liability guarantee for its subsidiary, Sichuan Bencao Tang Pharmaceutical Co., Ltd., which has a debt-to-asset ratio exceeding 70%, indicating potential risks associated with the guarantee [2][11]. Group 1: Guarantee Overview - The company approved a guarantee for Sichuan Bencao Tang to apply for a comprehensive credit limit of up to 1.368 billion RMB for financing needs [2][4]. - A maximum guarantee contract was signed with China Minsheng Bank Chengdu Branch, with the principal amount guaranteed being up to 100 million RMB [3][10]. Group 2: Subsidiary Information - Sichuan Bencao Tang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary with a registered capital of 125 million RMB, established on August 16, 2004 [5][6]. - The company holds a 56% stake in Sichuan Bencao Tang, which is engaged in various pharmaceutical and healthcare-related activities [6][7]. Group 3: Guarantee Agreement Details - The guarantee covers the principal debt, interest, penalties, and all costs associated with enforcing the debt and guarantee rights [8]. - The guarantee period is three years from the maturity date of each debt under the main contract [9]. Group 4: Necessity and Reasonableness of Guarantee - The guarantee is deemed necessary for the subsidiary's daily operations, with other shareholders providing counter-guarantees [11]. - The subsidiary is considered to have a normal debt repayment capacity, and the risks associated with the guarantee are manageable [11]. Group 5: Cumulative External Guarantee Amount - After this guarantee, the total external guarantee amount by the company and its subsidiaries is 1.28227 billion RMB, with a total balance of 903.1863 million RMB, accounting for 11.80% of the company's audited net assets for 2024 [12].